Home
Reels
Groups
Pages
See More
Groups Pages Events Blogs Offers Jobs Courses Movies Merits
Sign In Sign Up
Theme Switcher
Night Mode
Sponsored
Evolving Dynamics in the HER2-Low Cancer Landscape: Market Outlook and Growth Potential
Introduction The recognition of the “HER2-low” subgroup has significantly changed how clinicians and researchers view HER2 biology. Once categorized under HER2-negative disease, HER2-low tumors — typically defined as IHC 1+ or IHC 2+/ISH– — are now seen as actionable, particularly in breast cancer, following the breakthrough of antibody–drug conjugates...
0 Comments ·0 Shares ·240 Views ·0 Reviews
Please log in to like, share and comment!
Sponsored
Upgrade to Pro
Choose the Plan That's Right for You
Upgrade
Sponsored
Sponsored